To target the untargetable: elucidation of synergy of APR-246 and azacitidine in <i>TP53</i> mutant myelodysplastic syndromes and acute myeloid leukemia
David A. Sallman
Topics & Concepts
AzacitidineMyelodysplastic syndromesMyeloid leukemiaCancer researchMutantMyeloidLeukemiaMedicineBiologyImmunologyGeneGeneticsBone marrowDNA methylationGene expressionAcute Myeloid Leukemia ResearchSarcoma Diagnosis and TreatmentChronic Myeloid Leukemia Treatments